SMTL ID : 7tv9.1

HUMAN COMPLEMENT COMPONENT C3B IN COMPLEX WITH APL-1030

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.40 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 4 residues within 4Å: Chain A: V.21, M.61, N.63, A.481 No protein-ligand interaction detected (PLIP)

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 2 residues within 4Å: Chain A: N.178 Chain B: N.191 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Garlich, J. et al., Discovery of APL-1030, a Novel, High-Affinity Nanofitin Inhibitor of C3-Mediated Complement Activation. Biomolecules (2022)

Release Date

2022-03-30

Peptides

Complement C3 beta chain: A
Complement C3b alpha' chain: B
APL-1030 Nanofitin: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Complement C3 beta chain

Complement C3b alpha' chain

APL-1030 Nanofitin

Related Entries With Identical Sequence